The Amyotrophic Lateral Sclerosis diagnostic challenges necessitate more robust diagnostic and prognostic methods. A potential biomarker in this regard is the alterations of ferritin levels in the serum and cerebrospinal fluid of patients compared to controls.
The cerebrospinal fluid and serum ferritin levels were measured in 50 Amyotrophic Lateral Sclerosis cases and 50 control patients with predefined exclusion criteria. The ELISA method was utilized for laboratory measurement and was statistically analyzed using the SPSS.
Heightened serum ferritin levels in cases were not statistically significant, however, cerebrospinal fluid ferritin levels were significantly higher in Amyotrophic Lateral Sclerosis patients.
Serum ferritin levels were significantly negatively correlated with the disease duration and were significantly positively correlated with the disease progression rate.
Heightened cerebrospinal fluid ferritin levels can be used for the diagnosis of Amyotrophic Lateral Sclerosis. The correlation between the serum ferritin levels with the DPR and its correlation with the disease duration suggests potential prognostic utilities.
Read the original article on Pubmed
